Literature DB >> 30358186

BRCA genes: BRCA 1 and BRCA 2.

Umut Varol1, Yuksel Kucukzeybek, Ahmet Alacacioglu, Isil Somali, Zekiye Altun, Safiye Aktas, Mustafa Oktay Tarhan.   

Abstract

BRCA1 and BRCA2 are the genes related with breast and ovarian cancer. They have function in DNA repair processes and thus they are tumor suppressor genes. There are hundreds of mutations identified in these genes. Functional deficiencies due to these mutations impair DNA repair and cause irregularities in the DNA synthesis. The standard method for the laboratory assessment of these BRCA genes includes comprehensive sequencing and testing of broad genomic rearrangements. Members of the families with BRCA mutations have an increased risk for early onset of breast cancer and ovarian cancer occurring at any age. Surveillance of patients with mutations in BRCA 1/2 is done by yearly mammography and breast MRI and by transvaginal ultrasonography and serum CA-125 levels every 6-12 months for ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30358186

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  9 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

2.  Role of Previous Malignancy History in Clinical Outcomes in Patients with Initially Diagnosed Non-Muscle Invasive Bladder Cancer.

Authors:  Ryohei Kufukihara; Eiji Kikuchi; Koichiro Ogihara; Keisuke Shigeta; Yoshinori Yanai; Kimiharu Takamatsu; Hiroki Ide; Masafumi Oyama; Hirotaka Asakura; Ryuichi Mizuno; Mototsugu Oya
Journal:  Ann Surg Oncol       Date:  2021-03-05       Impact factor: 5.344

3.  Clinical characteristics and prognostic analysis of multiple primary malignant neoplasms in female patients with breast cancer or genitalia malignancies.

Authors:  Li Xiao; Tiantian Cao; Jiali Ou; Weijiang Liang
Journal:  PeerJ       Date:  2022-06-24       Impact factor: 3.061

4.  Bone health after RRBSO among BRCA1/2 mutation carriers: a population-based study.

Authors:  Helena Abreu do Valle; Paramdeep Kaur; Janice S Kwon; Rona Cheifetz; Lesa Dawson; Gillian E Hanley
Journal:  J Gynecol Oncol       Date:  2022-03-30       Impact factor: 4.756

5.  Enhance PARPi Application beyond BRCA-Mutant Breast Cancer (BC): Facts Are Facts.

Authors:  Tania Di Raimo; Francesco Angelini
Journal:  J Clin Med       Date:  2020-07-25       Impact factor: 4.241

6.  Five Italian Families with Two Mutations in BRCA Genes.

Authors:  Maria Teresa Vietri; Gemma Caliendo; Giovanna D'Elia; Marianna Resse; Amelia Casamassimi; Pellegrino Biagio Minucci; Concetta Dello Ioio; Michele Cioffi; Anna Maria Molinari
Journal:  Genes (Basel)       Date:  2020-12-03       Impact factor: 4.096

7.  BRCA role changes with association: tissue-specific impact on the prognosis.

Authors:  Bhavana Gupta; Kumaravel Somasundaram
Journal:  Oncotarget       Date:  2021-12-21

8.  Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.

Authors:  Mengying Tang; Mingchu Liao; Xiaohong Ai; Guicheng He
Journal:  Front Med (Lausanne)       Date:  2022-03-07

Review 9.  BARD1 and Breast Cancer: The Possibility of Creating Screening Tests and New Preventive and Therapeutic Pathways for Predisposed Women.

Authors:  Marcin Śniadecki; Michał Brzeziński; Katarzyna Darecka; Dagmara Klasa-Mazurkiewicz; Patryk Poniewierza; Marta Krzeszowiec; Natalia Kmieć; Dariusz Wydra
Journal:  Genes (Basel)       Date:  2020-10-24       Impact factor: 4.096

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.